| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-017-3837-9 |
| P8608 | Fatcat ID | release_kt5cmginfbalvmll2m54r3upxm |
| P698 | PubMed publication ID | 28914371 |
| P2093 | author name string | R A Silvestre | |
| Susana Mellor-Pita | |||
| Miguel Yebra-Bango | |||
| Pablo Tutor-Ureta | |||
| Raquel Castejon | |||
| Carlos Jimenez-Ortiz | |||
| Patricia Garcia-Garcia | |||
| P2860 | cites work | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 |
| Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis | Q28216384 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate | Q28295117 | ||
| Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study | Q33766242 | ||
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values' | Q34166955 | ||
| Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. | Q35032801 | ||
| Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness | Q35251472 | ||
| Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis | Q35511202 | ||
| Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus | Q35746107 | ||
| Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease | Q36211889 | ||
| 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus | Q36290168 | ||
| Cystatin C--a paradigm of evidence based laboratory medicine. | Q36869663 | ||
| Cystatin C associates with arterial stiffness in older adults | Q37181967 | ||
| Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study) | Q37259589 | ||
| Cystatin C and cardiovascular risk | Q37588315 | ||
| Association between high cystatin C levels and carotid atherosclerosis | Q37670965 | ||
| Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis | Q37719080 | ||
| Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis | Q39901357 | ||
| Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function | Q39999364 | ||
| Impact of Chronic Glucocorticoid Treatment on Cardiovascular Risk Profile in Patients with Systemic Lupus Erythematosus | Q41029663 | ||
| Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke | Q42366536 | ||
| Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). | Q42792026 | ||
| Association between cystatin C and arteriosclerosis in the absence of chronic kidney disease | Q44598105 | ||
| A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus | Q46905867 | ||
| Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors | Q46931963 | ||
| Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients. | Q51202425 | ||
| Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus. | Q51278001 | ||
| Predictive value of cystatin C in people with suspected or established coronary artery disease: A meta-analysis. | Q53232890 | ||
| Serum cystatin C, urinary neutrophil gelatinase-associated lipocalin and N-acetyl-beta-D-glucosaminidase in juvenile and adult patients with systemic lupus erythematosus: Correlation with clinical manifestations, disease activity and damage. | Q53799142 | ||
| Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction | Q83491038 | ||
| Serum cystatin C as a marker of renal function in patients with systemic lupus erythematosus | Q83829412 | ||
| P433 | issue | 12 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 2709-2717 | |
| P577 | publication date | 2017-09-15 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus | |
| P478 | volume | 36 |
| Q91695442 | Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis | cites work | P2860 |
Search more.